Qualiber Inc.
Unconventional liposomes for pancreatic cancer
This article was originally published in Start Up
Executive Summary
Many have tried to commercialize liposomal therapeutics, but only a few have succeeded. The founders of nanodelivery start-up Qualiber Inc. believe their method of creating smaller-than-typical, folate-targeted liposomes can yield a successful treatment for cancer and perhaps ultimately other indications.